• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5069344)   Today's Articles (26)
For: Shah R, Perry L, Deodhar A. The role of secukinumab in the treatment of ankylosing spondylitis. Immunotherapy 2015;7:1241-7. [PMID: 26595091 DOI: 10.2217/imt.15.93] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]  Open
Number Cited by Other Article(s)
1
Reich K, Warren R, Coates L, Di Comite G. Long‐term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease. J Eur Acad Dermatol Venereol 2020;34:1161-1173. [DOI: 10.1111/jdv.16124] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2019] [Accepted: 11/19/2019] [Indexed: 12/12/2022]
2
Synovial cell production of IL-26 induces bone mineralization in spondyloarthritis. J Mol Med (Berl) 2017;95:779-787. [PMID: 28365787 DOI: 10.1007/s00109-017-1528-2] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2016] [Revised: 02/26/2017] [Accepted: 03/20/2017] [Indexed: 12/31/2022]
3
Wendling D. Interleukin-17 targeted therapies in axial spondyloarthritis. Immunotherapy 2015;7:1125-8. [DOI: 10.2217/imt.15.85] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA